These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 9042907)
21. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Phelan CM; Lancaster JM; Tonin P; Gumbs C; Cochran C; Carter R; Ghadirian P; Perret C; Moslehi R; Dion F; Faucher MC; Dole K; Karimi S; Foulkes W; Lounis H; Warner E; Goss P; Anderson D; Larsson C; Narod SA; Futreal PA Nat Genet; 1996 May; 13(1):120-2. PubMed ID: 8673090 [TBL] [Abstract][Full Text] [Related]
22. BRCA1 and BRCA2 mutation analysis in 86 early onset breast/ovarian cancer patients. Garvin AM; Attenhofer-Haner M; Scott RJ J Med Genet; 1997 Dec; 34(12):990-5. PubMed ID: 9429140 [TBL] [Abstract][Full Text] [Related]
23. Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes. EC Demonstration Project on Familial Breast Cancer. Chang-Claude J; Becher H; Caligo M; Eccles D; Evans G; Haites N; Hodgson S; Møller P; Weber BH; Stoppa-Lyonnet D Dis Markers; 1999 Oct; 15(1-3):53-65. PubMed ID: 10595253 [TBL] [Abstract][Full Text] [Related]
24. Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden. Johannsson O; Ostermeyer EA; Håkansson S; Friedman LS; Johansson U; Sellberg G; Brøndum-Nielsen K; Sele V; Olsson H; King MC; Borg A Am J Hum Genet; 1996 Mar; 58(3):441-50. PubMed ID: 8644702 [TBL] [Abstract][Full Text] [Related]
25. Breast cancer susceptibility genes. BRCA1 and BRCA2. Brody LC; Biesecker BB Medicine (Baltimore); 1998 May; 77(3):208-26. PubMed ID: 9653432 [TBL] [Abstract][Full Text] [Related]
26. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Ford D; Easton DF; Stratton M; Narod S; Goldgar D; Devilee P; Bishop DT; Weber B; Lenoir G; Chang-Claude J; Sobol H; Teare MD; Struewing J; Arason A; Scherneck S; Peto J; Rebbeck TR; Tonin P; Neuhausen S; Barkardottir R; Eyfjord J; Lynch H; Ponder BA; Gayther SA; Zelada-Hedman M Am J Hum Genet; 1998 Mar; 62(3):676-89. PubMed ID: 9497246 [TBL] [Abstract][Full Text] [Related]
27. BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study. de Juan I; Palanca S; Domenech A; Feliubadaló L; Segura Á; Osorio A; Chirivella I; de la Hoya M; Sánchez AB; Infante M; Tena I; Díez O; Garcia-Casado Z; Vega A; Teulé À; Barroso A; Pérez P; Durán M; Carrasco E; Juan-Fita MJ; Murria R; Llop M; Barragan E; Izquierdo Á; Benítez J; Caldés T; Salas D; Bolufer P Fam Cancer; 2015 Dec; 14(4):505-13. PubMed ID: 26026974 [TBL] [Abstract][Full Text] [Related]
28. Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland. van Der Looij M; Wysocka B; Brozek I; Jassem J; Limon J; Olah E Hum Mutat; 2000 May; 15(5):480-1. PubMed ID: 10790213 [TBL] [Abstract][Full Text] [Related]
29. Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing. de la Hoya M; Osorio A; Godino J; Sulleiro S; Tosar A; Perez-Segura P; Fernandez C; Rodríguez R; Díaz-Rubio E; Benítez J; Devilee P; Caldés T Int J Cancer; 2002 Feb; 97(4):466-71. PubMed ID: 11802208 [TBL] [Abstract][Full Text] [Related]
30. BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers. Shih HA; Nathanson KL; Seal S; Collins N; Stratton MR; Rebbeck TR; Weber BL Clin Cancer Res; 2000 Nov; 6(11):4259-64. PubMed ID: 11106241 [TBL] [Abstract][Full Text] [Related]
31. Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer. Shiri-Sverdlov R; Oefner P; Green L; Baruch RG; Wagner T; Kruglikova A; Haitchick S; Hofstra RM; Papa MZ; Mulder I; Rizel S; Bar Sade RB; Dagan E; Abdeen Z; Goldman B; Friedman E Hum Mutat; 2000 Dec; 16(6):491-501. PubMed ID: 11102978 [TBL] [Abstract][Full Text] [Related]
32. Screening of male breast cancer and of breast-ovarian cancer families for BRCA2 mutations using large bifluorescent amplicons. Pages S; Caux V; Stoppa-Lyonnet D; Tosi M Br J Cancer; 2001 Feb; 84(4):482-8. PubMed ID: 11207042 [TBL] [Abstract][Full Text] [Related]
33. BRCA2 germline mutations in male breast cancer cases and breast cancer families. Couch FJ; Farid LM; DeShano ML; Tavtigian SV; Calzone K; Campeau L; Peng Y; Bogden B; Chen Q; Neuhausen S; Shattuck-Eidens D; Godwin AK; Daly M; Radford DM; Sedlacek S; Rommens J; Simard J; Garber J; Merajver S; Weber BL Nat Genet; 1996 May; 13(1):123-5. PubMed ID: 8673091 [TBL] [Abstract][Full Text] [Related]
34. Genetic testing for breast cancer susceptibility: frequency of BRCA1 and BRCA2 mutations. Ganguly A; Leahy K; Marshall AM; Dhulipala R; Godmilow L; Ganguly T Genet Test; 1997; 1(2):85-90. PubMed ID: 10464631 [TBL] [Abstract][Full Text] [Related]
35. Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families. Osorio A; Barroso A; Martínez B; Cebrián A; San Román JM; Lobo F; Robledo M; Benítez J Br J Cancer; 2000 Apr; 82(7):1266-70. PubMed ID: 10755399 [TBL] [Abstract][Full Text] [Related]
36. Exclusion of large deletions and other rearrangements in BRCA1 and BRCA2 in Finnish breast and ovarian cancer families. Lahti-Domenici J; Rapakko K; Pääkkönen K; Allinen M; Nevanlinna H; Kujala M; Huusko P; Winqvist R Cancer Genet Cytogenet; 2001 Sep; 129(2):120-3. PubMed ID: 11566341 [TBL] [Abstract][Full Text] [Related]
37. Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families. Stadler ZK; Saloustros E; Hansen NA; Schluger AE; Kauff ND; Offit K; Robson ME Breast Cancer Res Treat; 2010 Sep; 123(2):581-5. PubMed ID: 20221693 [TBL] [Abstract][Full Text] [Related]
39. BRCA1 and BRCA2 in breast cancer. Yang X; Lippman ME Breast Cancer Res Treat; 1999 Mar; 54(1):1-10. PubMed ID: 10369075 [TBL] [Abstract][Full Text] [Related]
40. BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and ovarian cancer. Schubert EL; Mefford HC; Dann JL; Argonza RH; Hull J; King MC Genet Test; 1997; 1(1):41-6. PubMed ID: 10464624 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]